A New Path to HCC Knowledge

Rafscience.com is an educational resource for medical professionals interested in learning more about the role of the RAF kinase cell signaling pathway in hepatocellular carcinoma (HCC). Activated RAS "turns on" the serine threonine-protein kinase known as RAF kinase, which then activates downstream effectors involved in many aspects of tumorigenesis—from cell immortalization to angiogenesis and drug resistance. Keep visiting this site as new knowledge emerges on the role of RAF kinase in tumorigenesis.

Learn More About RAF Kinase Pathway in HCC

Signaling pathways for cell proliferation and survival.

At Risk Populations

Hepatitis viruses are responsible for over 80% of HCC cases worldwide.

- a A + text zoom
Site Updates
Sign up now to receive email notifications as new knowledge emerges on the role of RAF kinase in tumorigenesis. Register Now
Information for Patients
Explore the molecular basis of Hepatocellular Carcinoma (HCC) in this detailed slide kit. View Slideshow
Bayer Pharmaceuticals Healthcare Onyx Pharmaceuticals
A new path to HCC Knowledge